Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere

Clin Pediatr (Phila). 2017 Aug;56(9):805-810. doi: 10.1177/0009922817706148. Epub 2017 May 1.

Authors

H Patrick Stern¹, Jonathan Lipman^{2

3}, Susan L Andersen^{4

5}, John B Bossaer⁶, Jim Thigpen⁶

Affiliations

¹ 1 Developmental-Behavioral Pediatrician (Retired), Telford, TN, USA.
² 2 Neuroscience Consulting, Inc, Unicoi, TN, USA.
³ 3 Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
⁴ 4 Harvard Medical School, Boston, MA, USA.
⁵ 5 McLean Hospital, Belmont, MA, USA.
⁶ 6 Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA.

PMID: 28459152
DOI: 10.1177/0009922817706148

No abstract available

Publication types

Review

MeSH terms

Adolescent
Amphetamines / adverse effects*
Attention Deficit Disorder with Hyperactivity / drug therapy*
Brain / drug effects*
Central Nervous System Stimulants / adverse effects*
Child
Child, Preschool
Humans
Methylphenidate / adverse effects*
Prognosis

Substances

Amphetamines
Central Nervous System Stimulants
Methylphenidate